Shares to Trade Under the Symbol NEPT
LAVAL, QC, Aug. 13 /CNW Telbec/ - Neptune Technologies &
Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB) announced today that its shares
will begin trading on the NASDAQ Stock Market under the symbol NEPT on Monday,
August 13 at the opening bell. Neptune Technologies & Bioressources (NTB)
extracts, scientifically validates, and markets natural health products
extracted from marine biomasses, and currently provides the world's only
FDA-approved oil from krill.
- COMPANY NAME NEPTUNE TECHNOLOGIES & BIORES
- STOCK SYMBOL NEPT
- STOCK MARKET NASDAQ CAPITAL MARKET
- START TRADING AUGUST 13, 2007 OPENING BELL
About Neptune Technologies & Bioressources, Inc.
Neptune Technologies & Bioressources Inc. develops proprietary and potent
health ingredients from underexploited marine biomasses, such as krill, with
its patented extraction process (Neptune OceanExtract(TM)). Using its
proprietary process, Neptune Technologies & Bioressources Inc. is
strategically positioning itself in the health and wellness market.
Natural biomass extraction is now playing an important role in developing
nutrigenomics, the next wave in nutritional research. Through strategic
alliances and partnerships, as well as through clinical studies, the Company
continues to demonstrate the immense beneficial effects of these products. The
Company develops and markets new formulas and new products for specific
applications in high growth markets such as the nutraceutical, cosmeceutical,
biopharmaceutical and nutrigenomics markets.
TSX venture exchange does not accept responsibility for the adequacy or
accuracy of this press release.
Statements in this press release that are not statements of historical or
current fact constitute "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks, uncertainties, and other unknown
factors that could cause the actual results of the Company to be materially
different from historical results or from any future results expressed or
implied by such forward-looking statements. In addition to statements which
explicitly describe such risks and uncertainties, readers are urged to
consider statements labeled with the terms "believes," "belief," "expects,"
"intends," "anticipates," "will," or "plans" to be uncertain and
forward-looking. The forward-looking statements contained herein are also
subject generally to other risks and uncertainties that are described from
time to time in the Company's reports filed with the Securities and Exchange
%SEDAR: 00015144E %CIK: 0001401395
For further information:
For further information: US Contact: John Tsemberides, ROI Group LLC,
(212) 495-0743, email@example.com; Company Contact: André Godin, V-P,
Administration and Finance, Neptune Technologies & Bioressources, Inc.,
agodin@neptunebiotech..com; Canada Contact: Grant Howard, The Howard Group
Inc., (888) 221-0915, firstname.lastname@example.org; www.neptunebiotech.com